Inhibiting biofilm formation by Klebsiella pneumoniae B5055 using an iron antagonizing molecule and a bacteriophage

BMC Microbiology

Volumn 13, Issue 1, 2013, Pages

  Chhibber, Sanjay ^a   Nag, Deepika ^a   Bansal, Shruti ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Adjunct; Alternate therapy; Phage depolymerase; Resistance; Treatment

Indexed keywords

COBALT; IRON;

ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOPHAGE; BIOFILM; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXAMINATION; KLEBSIELLA PNEUMONIAE; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; MOLECULE; NONHUMAN; REDUCTION; SUPPLEMENTATION;

BACTERIOPHAGES; BIOFILMS; CATIONS, DIVALENT; COBALT; IRON; KLEBSIELLA PNEUMONIAE; MICROBIAL VIABILITY;

BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

EID: 84880906621     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-13-174     Document Type: Article

References (23)

1. Signals, regulatory networks, and materials that build and break bacterial biofilms. Karatan E, Watnick P, Microbiol Mol Biol Rev 2009 5 310 347
2. Biofilms: survival mechanisms of clinically relevant microorganisms. Donlan RM, Costerton JW, Clin Microbiol Rev 2002 15 167 10.1128/CMR.15.2.167- 193.2002 11932229 (Pubitemid 34303762)
3. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods and pathogenicity factors. Podschun R, Ullmann U, Clin Microbiol Rev 1998 11 589 603 9767057 (Pubitemid 28497563)
4. Mechanisms of biofilm resistance to antimicrobial agents. Mah TF, O'Toole GA, Trends Microbiol 2001 9 34 39 10.1016/S0966-842X(00)01913-2 11166241 (Pubitemid 32467503)
5. The potential role of endogenous bacteriophages in controlling invading pathogens. Górski A, Weber-Dabrowska B, Cell Mol Life Sci 2005 62 511 519 10.1007/s00018-004-4403-6 15747058 (Pubitemid 40386333)
6. Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. Parisien A, Allain B, Zhang J, Mandeville R, Lan CQ, J Appl Microbiol 2008 104 1 13 18171378 (Pubitemid 350265294)
7. Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Hughes KA, Sutherland IW, Clark J, Jones MV, Microbiology 1998 144 3039 3047 10.1099/00221287-144-11-3039 9846739 (Pubitemid 28515582)
8. The use of phages for the removal of infectious biofilms. Azeredo J, Sutherland IW, Curr Pharm Biotechnol 2008 9 261 266 10.2174/138920108785161604 18691087
9. Suppression of bacterial biofilm formation by iron limitation. Weinberg ED, Med Hypotheses 2004 63 863 865 10.1016/j.mehy.2004.04.010 15488661 (Pubitemid 39370008)
10. Chelator induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Banin E, Brady KM, Greenberg EP, Appl Environ Microbiol 2006 72 2064 2069 10.1128/AEM.72.3.2064-2069.2006 16517655
11. Iron availability influences aggregation, biofilm adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Berlutti N, Morea C, Battistoni A, Sarli S, Cipriani P, Superti F, Ammendolia MG, Int J Imunopathol Pharmacol 2005 18 661 670
12. Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa. Musk DJ, Banko DA, Hergenrother P, J Chem Biol 2005 12 789 796 10.1016/j.chembiol.2005.05.007 (Pubitemid 41009158)
13. Iron and Pseudomonas aeruginosa biofilm formation. Banin E, Vasil ML, Greenberg EP, Proc Natl Acad Sci 2005 102 11076 11078 10.1073/pnas.0504266102 16043697 (Pubitemid 41105995)
14. Iron binding compounds impair Pseudomonas aeruginosa biofilm formation especially under anaerobic conditions. O'May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW, J Med Microbiol 2009 58 765 773 10.1099/jmm.0.004416-0 19429753
15. Abolition of biofilm formation in urinary tract Escherichia coli and Klebsiella isolates by metal interference through competition for Fur. Hancock V, Dahl M, Klemm P, Appl Environ Microbiol 2010 72 3836 3841
16. Characterization of a T7-Like Lytic Bacteriophage of Klebsiella pneumoniaeB5055: a potential therapeutic agent. Verma V, Harjai K, Chhibber S, Curr Microbiol 2009 59 274 281 10.1007/s00284-009-9430-y 19484297
17. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. Verma V, Harjai K, Chhibber S, J Antimicrob Chemother 2009 64 1212 1218 10.1093/jac/dkp360 19808232
18. Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Verma V, Harjai K, Chhibber S, Biofouling 2010 26 729 737 10.1080/08927014.2010.511196 20711894
19. Adams MH, Bacteriophages New York: Interscience 1959
20. Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. Bedi MS, Verma V, Chhibber S, World J Microb Biot 2009 25 1145 1151 10.1007/s11274-009-9991-8
21. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Anderl JN, Stewart PS, Franklin MJ, Antimicrob Agents Chemother 2000 44 1818 1824 10.1128/AAC.44.7. 1818-1824.2000 10858336 (Pubitemid 30422930)
22. Iron uptake by Escherichia coli. Braun V, Front Biosci 2003 8 1409 1421 10.2741/1232
23. Iron chelation directed against biofilms as an adjunct to conventional antibiotics. Reid DW, O'May C, Kirov SM, Roddam L, Lamont IL, Sanderson K, Am J Physiol Lung Cell Mol Physiol 2009 296 857 858